We’re honoured to be recognised as 'Notable" in the IFLR1000 2025–2026 (35th edition) for both "M&A" and "Banking & Finance." This...

Congratulations to our Managing Director & Head of M&A, Azmul Haque, on being recognised as 'Highly Regarded Lawyer' and our Director &...

Collyer Law has been named as a finalist in the ALB PAN ASIAN REGULATORY AWARDS 2025 in the category "Regulatory Law Firm of the Year -...

Collyer Law has been named as a finalist at the Asia Legal Awards 2025 in the category " Boutique Law Firm of the Year". The awards, now...

Collyer Law advised a Singapore-based health and longevity clinic focused on reversing biological aging, on its SAFE investment round from an international venture capital fund. The funding will support clinical research, product development and market expansion.